Researchers look to the ancestral genes of influenza to develop a new approach to vaccination
A truly universal flu vaccine continues to evade scientists, but it should be possible to develop a vaccine that offers broader strain protection – and lasts longer. Eric Weaver, assistant professor at the University of Nebraska, certainly believes we can do better when it comes to influenza vaccines; his team have developed a vaccine that carries the centralized genes for H1, H2, H3, and H5, with the aim of providing immunity against all evolved strains (1). We speak with Weaver to learn more.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine